Top Page
Regis Healthcare Ltd.
(Sydney:REG)
Regis Healthcare Ltd. (REG) vs. iShares MSCI Australia ETF (EWA)
Regis Healthcare Ltd. Business Overview & Revenue Model
Regis Healthcare Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.16B | 1.15B | 1.01B | 771.48M | 717.89M | 685.87M |
| Gross Profit | 168.77M | 141.46M | 47.17M | -3.78M | 5.18M | 67.54M |
| EBITDA | 182.10M | 240.44M | 191.45M | 96.81M | 55.86M | 82.65M |
| Net Income | 48.95M | 48.95M | -21.41M | -28.45M | -38.80M | 19.95M |
Balance Sheet | ||||||
| Total Assets | 2.11B | 2.11B | 1.81B | 1.71B | 1.76B | 1.75B |
| Cash, Cash Equivalents and Short-Term Investments | 192.47M | 192.47M | 64.91M | 61.32M | 4.15M | 3.89M |
| Total Debt | 5.11M | 5.11M | 3.84M | 71.07M | 113.32M | 153.41M |
| Total Liabilities | 2.12B | 2.12B | 1.84B | 1.67B | 1.68B | 1.61B |
| Stockholders Equity | -16.72M | -16.72M | -22.89M | 38.39M | 79.01M | 141.97M |
Cash Flow | ||||||
| Free Cash Flow | 219.64M | 219.64M | 186.57M | 53.73M | 67.60M | 87.75M |
| Operating Cash Flow | 306.11M | 306.11M | 252.30M | 105.16M | 114.79M | 105.03M |
| Investing Cash Flow | -132.74M | -132.74M | -136.59M | 6.58M | -48.62M | 7.50M |
| Financing Cash Flow | -45.81M | -45.81M | -112.12M | -43.17M | -62.39M | -119.47M |
Regis Healthcare Ltd. Technical Analysis
Regis Healthcare Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | AU$512.17M | 15.86 | 18.59% | 4.72% | 6.73% | 37.16% | |
63 Neutral | ― | ― | 3.28% | ― | 9.05% | -75.79% | |
56 Neutral | AU$2.17B | 43.32 | ― | 2.26% | 14.61% | ― | |
55 Neutral | AU$902.48M | 163.16 | 0.94% | 2.62% | 33.54% | ― | |
54 Neutral | AU$7.93B | 1,199.66 | 0.38% | 2.25% | 6.82% | -99.27% | |
53 Neutral | AU$227.15M | -2.46 | -90.93% | ― | 456.50% | -457.14% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Regis Healthcare Ltd. Corporate Events
Regis Healthcare Limited has announced the sale of two residential aged care homes in Far North Queensland to Ozcare, a not-for-profit provider. This divestment is part of Regis’ strategy to optimize its national portfolio and focus on high-demand, premium locations. The transaction is expected to yield a one-off pre-tax gain of approximately $25 million, which will be reflected in the company’s FY26 financial results. The sale is anticipated to be completed by March 2026, ensuring a smooth transition for residents, families, and staff. Additionally, Regis has recently completed the acquisition of two facilities in Victoria, further expanding its presence in the region.
Regis Healthcare Ltd announced a change in the director’s interest, with Linda Jane Mellors being granted 115,236 performance rights under the FY26 Long-Term Incentive (LTI) plan. This grant, approved at the Annual General Meeting, is part of a strategy to align the director’s interests with company performance over a three-year period, potentially impacting the company’s governance and stakeholder confidence.
Regis Healthcare Ltd. has announced the issuance of 305,330 performance rights under an employee incentive scheme, which are not intended to be quoted on the ASX. This move reflects the company’s strategy to incentivize and retain its workforce, potentially enhancing employee engagement and aligning their interests with the company’s long-term objectives.
Regis Healthcare Limited announced the results of its Annual General Meeting, where all resolutions, including the re-election of directors and the adoption of the FY25 remuneration report, were successfully carried. The approval of performance rights for the CEO under the long-term incentive plan and the reinsertion of the proportional takeover approval provision were also confirmed, reflecting strong shareholder support and strategic alignment.
Regis Healthcare Ltd’s recent Annual General Meeting highlighted its focus on improving care outcomes and sustainable business growth. The company reported significant improvements in key performance indicators and employee engagement, alongside a multi-pronged investment strategy. This includes greenfield developments, with new facilities like Regis Camberwell achieving full occupancy, and ongoing construction in other locations. Regis is also expanding its development pipeline and pursuing strategic acquisitions to meet its goal of operating 10,000 quality beds by FY28, reflecting its commitment to adapting to the growing demand and evolving needs in the aged care sector.
Regis Healthcare Limited has announced the acquisition of two high-quality aged care homes, Ocean Mist Aged Care and Drysdale Grove Aged Care, located on Victoria’s Surf Coast and Bellarine Peninsula. This strategic acquisition, valued at approximately $45 million, will expand Regis’ footprint in Victoria, adding 230 beds to its portfolio. The transaction, expected to complete by December 2025, aligns with Regis’ strategy to broaden its residential aged care services and is anticipated to be earnings per share accretive by FY26. The acquisition not only enhances Regis’ market presence but also offers potential cost synergies and increased earnings through higher occupancy and room pricing.
Regis Healthcare Ltd announced a change in the director’s interest notice, specifically regarding Dr. Linda Jane Mellors. The company canceled 4,688 rights granted to Dr. Mellors under the FY2023 Long Term Incentive plan due to unmet performance conditions. This adjustment reflects the company’s adherence to performance-based incentive structures, potentially impacting the director’s future compensation and aligning with shareholder interests.
Regis Healthcare Ltd. announced the cessation of 12,235 performance rights due to the conditions for these securities not being met. This development may impact the company’s capital structure and could have implications for stakeholders, reflecting on the company’s operational adjustments and strategic focus.
Regis Healthcare Ltd. announced the quotation of 154,160 ordinary fully paid securities on the ASX, issued under an employee incentive scheme. This move could enhance the company’s market presence and provide liquidity options for its stakeholders, reflecting its strategic efforts to strengthen employee engagement and align interests with company performance.
Regis Healthcare Ltd. has announced its 2025 Annual General Meeting, scheduled for November 18, 2025, in a hybrid format. Key agenda items include the re-election of directors, adoption of the remuneration report, and approval of performance rights for the CEO. Shareholders are encouraged to participate and submit proxy votes in advance to ensure their voices are heard.
Regis Healthcare Ltd. has announced the quotation of 538,305 ordinary fully paid securities on the Australian Securities Exchange (ASX) as part of an employee incentive scheme. This move is expected to enhance the company’s market presence and potentially improve stakeholder value by aligning employee interests with company growth.
Regis Healthcare Ltd announced a change in the director’s interest, specifically regarding Linda Jane Mellors. The change involved the cessation of performance rights under the FY24 STI Plan, where a cash equivalent payment was made instead of allocating ordinary shares. This decision reflects the company’s strategic financial management approach, potentially impacting its financial operations and signaling a focus on liquidity management.
Regis Healthcare Ltd. announced the cessation of 30,840 performance rights, which were canceled by agreement between the entity and the holder as of September 27, 2025. This move may impact the company’s capital structure and could have implications for its financial strategy and stakeholder interests.
Regis Healthcare Limited has announced updates regarding changes in residential aged care funding by the Australian Government, which include a 4.7% increase in the AN-ACC industry starting price. However, Regis anticipates a funding increase of only 2.6% due to reweighting in the National Weighted Activity Unit, leading to reduced funding for key resident classifications. This shortfall, combined with rising staff costs, poses financial challenges. Despite this, the successful acquisition of four Rockpool homes and strong occupancy rates are expected to support cash flows and growth initiatives. Regis projects an FY26 Underlying EBITDA growth of 3% to 7%, reaching $130m to $135m, influenced by these funding changes and operational developments.
Regis Healthcare Limited has acknowledged the Australian Government’s recent announcement regarding increased pricing for the Australian National Aged Care Classification (AN-ACC) and hotelling supplement. These changes are aimed at funding wage increases for direct care workers and nurses as per the Fair Work Commission’s recommendations. Regis is currently assessing the financial implications of these changes and will continue to update the market in line with its disclosure obligations.